Alec Vahanian
About
In The Last Decade
Alec Vahanian
399 papers receiving 22.6k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cardiology and Cardiovascular Medicine 21.5k
- Epidemiology 11.5k
- Surgery 7.6k
- Pulmonary and Respiratory Medicine 5.0k
- Radiology, Nuclear Medicine and Imaging 4.5k
Countries citing papers authored by Alec Vahanian
This map shows the geographic impact of Alec Vahanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec Vahanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec Vahanian more than expected).
Fields of papers citing papers by Alec Vahanian
This network shows the impact of papers produced by Alec Vahanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec Vahanian. The network helps show where Alec Vahanian may publish in the future.
Co-authorship network of co-authors of Alec Vahanian
This figure shows the co-authorship network connecting the top 25 collaborators of Alec Vahanian. A scholar is included among the top collaborators of Alec Vahanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec Vahanian. Alec Vahanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 46 | |
| 3 | 21 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 54 | |
| 7 | Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper breakdown → | 199 |
| 8 | 5 | |
| 9 | 28 | |
| 10 | 11 | |
| 11 | 40 | |
| 12 | 25 | |
| 13 | 14 | |
| 14 | Two Year Results With Transcatheter Treatment of Functional Mitral Regurgitation With the MONARC (TM) System In the EVOLUTION I Study | 4 |
| 15 | Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention | 3 |
| 16 | [Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. | 6 |
| 17 | 83 | |
| 18 | 23 | |
| 19 | 3 | |
| 20 | [Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.